Pharma firm Lupin today said it has launched a generic version of Femcon Fe,

RELATED ARTICLES Tapi pipeline perfect example of energy diversification: US India to move WTO this week against US visa fee hike Dr Reddy's launches lansoprazole capsules in US market Nasscom concerned over US visa probe on Indian firms Rajat Gupta to face US jury in insider trading case

birth control chewable tablets, in the US market.

It's US-based subsidiary Lupin Pharmaceuticals Inc has launched the generic version of Warner Chilcott's Femcon Fe Chewable tablets in strengths of 0.4mg/35mcg, the company said in a statement.

Commenting on the launch, Lupin Group President Nilesh Gupta said: "We are very pleased to commercialise the authorised generic for Femcon. Consumers can be assured they are receiving the same product they have been accustomed to at an affordable price".

Femcon Fe (norethindrone and ethinyl estradiol, chewable and ferrous fumarate) is low-dose chewable, birth control tablet that can also be taken with liquid, the company said.

Shares of Lupin were trading at Rs 465.70 on the BSE in afternoon trade, up 2 per cent from its previous close.